Conflict of Interest

Thomas Jefferson University endorses the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards. All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.

All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.  Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Such disclosures will be available prior to the start of the activity. ​Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Exception: According to the Standards, it is not required to identify, mitigate, or disclose relevant financial relationships for any of the following activities:

1. Accredited education that is non-clinical, such as leadership or communication skills training.
2. Accredited education where the learner group is in control of content, such as a spontaneous case conversation among peers.
3. Accredited self-directed education where the learner controls their educational goals and reports on changes that resulted, such as learning from teaching, remediation, or a personal development plan.

PLANNING COMMITTEE

Mary Reich Cooper, MD JD-Activity Director
Ellen Guarnieri, RN, MHSA, CPHQ, FACHE
Richard Hass, PhD
Maureen Frye, MSN, ANP-BC, CRNP, CPPS, CPHQ

PRESENTERS

Maureen Frye, MSN, ANP-BC, CRNP, CPPS, CPHQ

Off‐label/Investigational Use

This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.

Content Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, or Thomas Jefferson University, or the Joint Provider(s).

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.